Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation of membrane-permeable cyclic peptides inhibiting protein-protein interaction.

Nature chemical biology·2026
Same author

Yeast Display Technology Enables Rapid Discovery of Low-Nanomolar Macrocyclic Peptide Inhibitors of Human Angiotensin-Converting Enzyme 2.

Journal of medicinal chemistry·2026
Same author

Ligand-Directed Site-Selective Cysteine Bioconjugation of the KELCH Domain of KEAP1 with Hypervalent Iodine Reagents.

Journal of the American Chemical Society·2025
Same author

Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking.

Nature communications·2025
Same author

Biodiversity2Drugs-Renaissance of exploring nature-derived peptides for GPCR ligand discovery.

British journal of pharmacology·2025
Same author

Phage Display Selection against a Mixture of Protein Targets.

ACS chemical biology·2025
Same journal

How Much Chirality is Enough?

Chimia·2026
Same journal

Raman Optical Activity (ROA) as an Emerging Standard in Molecular Chirality Measurements - A Perspective.

Chimia·2026
Same journal

Molecular Chirality: From Structure to the Quantum Dynamics of Tunnelling, Parity Violation, a Molecular Quantum Switch and the Possible Astrophysical Detection of Homochirality as a Signature of Extraterrestrial Life.

Chimia·2026
Same journal

Shining Light on Chiral Monolayer-protected Metal Clusters.

Chimia·2026
Same journal

Spin Depolarization Mechanisms in Halide Perovskite Semiconductors.

Chimia·2026
Same journal

New Insights into Circularly Polarized Luminescence from Chromium(III) Spin-Flip Emitters.

Chimia·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

Bicyclic peptide antagonists derived from genetically encoded combinatorial libraries.

Christian Heinis1

  • 1Ecole Polytechnique Fédérale de Lausanne, EPFL Institute of Chemical Sciences and Engineering, CH1015 Lausanne. christian.heinis@epfl.ch

Chimia
|October 27, 2011
PubMed
Summary
This summary is machine-generated.

Bicyclic peptides offer therapeutic potential by combining antibody-like specificity with small molecule advantages. Researchers are developing these peptide antagonists for targeted protein therapies using phage display and chemical cyclization.

More Related Videos

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library
13:37

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

Related Experiment Videos

Last Updated: May 28, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library
13:37

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

Area of Science:

  • Medicinal Chemistry
  • Biotechnology
  • Drug Discovery

Background:

  • Bicyclic peptides present a promising scaffold for therapeutic development.
  • They integrate the high binding affinity and specificity of antibodies with the stability and synthetic accessibility of small molecules.
  • These properties make them suitable for drug design and development.

Purpose of the Study:

  • To generate novel bicyclic peptide antagonists targeting specific proteins.
  • To explore the therapeutic potential of bicyclic peptides.
  • To establish a method for creating targeted peptide-based therapeutics.

Main Methods:

  • Utilizing a combinatorial approach.
  • Employing phage display technology for ligand discovery.
  • Implementing a chemical cyclization reaction for peptide structure formation.

Main Results:

  • Successful generation of bicyclic peptide antagonists.
  • Demonstration of a viable method for creating these molecules.
  • Laying the groundwork for therapeutic applications.

Conclusions:

  • Bicyclic peptides are viable candidates for therapeutic development.
  • The described methodology enables the creation of targeted peptide antagonists.
  • This approach holds promise for future drug discovery efforts.